Ananda Ghosh
Stock Analyst at HC Wainwright & Co.
(2.52)
# 3,312
Out of 4,984 analysts
6
Total ratings
83.33%
Success rate
9.28%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ananda Ghosh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MAZE Maze Therapeutics | Maintains: Buy | $34 → $50 | $23.50 | +112.77% | 2 | Sep 12, 2025 | |
| RNA Avidity Biosciences | Maintains: Buy | $68 → $87 | $40.06 | +117.17% | 1 | Sep 12, 2025 | |
| IVA Inventiva | Assumes: Buy | $20 | $5.28 | +278.86% | 1 | Sep 3, 2025 | |
| ANNX Annexon | Reiterates: Buy | $14 | $2.53 | +453.36% | 1 | Aug 15, 2025 | |
| GPCR Structure Therapeutics | Maintains: Buy | $75 → $60 | $21.65 | +177.14% | 1 | Aug 7, 2025 |
Maze Therapeutics
Sep 12, 2025
Maintains: Buy
Price Target: $34 → $50
Current: $23.50
Upside: +112.77%
Avidity Biosciences
Sep 12, 2025
Maintains: Buy
Price Target: $68 → $87
Current: $40.06
Upside: +117.17%
Inventiva
Sep 3, 2025
Assumes: Buy
Price Target: $20
Current: $5.28
Upside: +278.86%
Annexon
Aug 15, 2025
Reiterates: Buy
Price Target: $14
Current: $2.53
Upside: +453.36%
Structure Therapeutics
Aug 7, 2025
Maintains: Buy
Price Target: $75 → $60
Current: $21.65
Upside: +177.14%